Pittsboro based biotech startup is sold to Japanese firm for $175M
Startup biotech Propella Therapeutics is being acquired by Japan-based Astella Pharma in a deal valued at $175 million. Here are the details.
Stay updated with breaking news from Astella Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Startup biotech Propella Therapeutics is being acquired by Japan-based Astella Pharma in a deal valued at $175 million. Here are the details.
Business Strategy Total Supply Chain Services The Alfresa Group provides unique ...
Women with obesity experience greater menopausal symptoms but substantially less relief from hormone therapy than women without obesity, according to a study.
/PRNewswire/ -- Allied Market Research published a report, titled, "Chemotherapy Induced Anemia Market by Grade (Grade 1, Grade 2, and Grade 3 & 4), Treatment...
The U.S. Food and Drug Administration on Friday approved Veozah, a new type of drug to treat hot flashes and night sweats during menopause.